FoRx Therapeutics Revenue and Competitors

License our Company Data API

Basel,

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

FoRx Therapeutics's estimated annual revenue is currently $5.1M per year.(i)
FoRx Therapeutics's estimated revenue per employee is $155,000

Employee Data

FoRx Therapeutics has 33 Employees.(i)
FoRx Therapeutics grew their employee count by 38% last year.

FoRx Therapeutics's People

Name	Title	Email/Phone

FoRx Therapeutics Competitors & AlternativesAdd Company

Competitor Name	Revenue	Number of Employees	Employee Growth	Total Funding	Valuation
#1 Dermavant Scien...	$81.4M	375	40%	N/A	N/A
#2 Metrum Research...	$16.9M	109	22%	N/A	N/A
#3 Clovis Oncology	$156.1M	120	-70%	$145M	N/A
#4 ArcherDX	$2.9M	37	-24%	$150M	N/A
#5 Inscripta	$1.3M	17	0%	$459.5M	N/A
#6 Cerapedics	$49.2M	254	15%	$180.7M	N/A
#7 Stone Clinical ...	$7M	45	-2%	N/A	N/A
#8 Apellis Pharmac...	$256.3M	840	9%	$168.5M	N/A
#9 CreoSalus	$4.2M	27	-7%	N/A	N/A
#10 MSBiotec	$10.1M	65	5%	N/A	N/A

Add Company

Show More Biotech Companies

What Is FoRx Therapeutics?

FoRx Therapeutics is a recently incorporated privately-held company based in Basel, Switzerland. It is backed by a syndicate of investors that include the Novartis Venture Fund, Pfizer Ventures, M Ventures, Omega Funds and LSP Venture Capital. FoRx Therapeutics focuses on drugging key molecular targets involved in the DNA Replication Stress, as a new approach in the development of targeted anticancer drugs.

keywords:N/A

N/A

Total Funding

Number of Employees

$5.1M

Revenue (est)

38%

Employee Growth %

N/A

Valuation

N/A

Accelerator